The latest price target for (:SGEN) was reported by Truist Securities on October 18, 2023. The analyst firm set a price target for $229.00 expecting SGEN to fall to within 12 months (a possible NaN% downside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for (:SGEN) was provided by Truist Securities, and reiterated their hold rating.

The last upgrade for happened on February 16, 2023 when Evercore ISI Group raised their price target to $175. Evercore ISI Group previously had an in-line for .

The last downgrade for happened on March 24, 2023 when Berenberg changed their price target from $170 to $229 for .

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of , and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.

While ratings are subjective and will change, the latest (SGEN) rating was a reiterated with a price target of $0.00 to $229.00. The current price (SGEN) is trading at is $undefined, which is out of the analyst’s predicted range.